Citigroup
GBT

Citigroup’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Citigroup’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,200
Closed -$961K – 7722
2020
Q4 		$961K Buy
22,200
+3,500
+19% +$173K ﹤0.01% 3577
2020
Q3 		$1.03M Sell
18,700
-16,000
-46% -$1.02M ﹤0.01% 3248
2020
Q2 		$2.19M Buy
34,700
+17,000
+96% +$1.17M ﹤0.01% 2711
2020
Q1 		$904K Sell
17,700
-25,100
-59% -$1.68M ﹤0.01% 3288
2019
Q4 		$3.4M Buy
42,800
+9,700
+29% +$575K ﹤0.01% 2391
2019
Q3 		$1.61M Sell
33,100
-8,400
-20% -$438K ﹤0.01% 3109
2019
Q2 		$2.18M Buy
41,500
+21,200
+104% +$1.22M ﹤0.01% 2756
2019
Q1 		$1.07M Buy
20,300
+10,100
+99% +$496K ﹤0.01% 3325
2018
Q4 		$419K Sell
10,200
-5,000
-33% -$187K ﹤0.01% 4329
2018
Q3 		$578K Sell
15,200
-18,500
-55% -$819K ﹤0.01% 4106
2018
Q2 		$1.52M Buy
33,700
+27,700
+462% +$1.26M ﹤0.01% 2941
2018
Q1 		$290K Buy
6,000
+1,500
+33% +$83.7K ﹤0.01% 4563
2017
Q4 		$177K Buy
4,500
+3,900
+650% +$146K ﹤0.01% 5165
2017
Q3 		$19K Buy
+600
New +$16.9K ﹤0.01% 6464
2017
Q2 		– Sell
-8,000
Closed -$295K – 7547
2017
Q1 		$295K Buy
8,000
+6,000
+300% +$151K ﹤0.01% 4324
2016
Q4 		$29K Buy
+2,000
New +$35.1K ﹤0.01% 6390

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's GBT Position: Q4 2022 in Review

Citigroup sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 1,586,334 shares — an estimated $108M sold.

Citigroup first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $108M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Citigroup reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 1,586,334 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $108M.
  • Citigroup first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
  • Citigroup's Global Blood Therapeutics, Inc. position peaked at $108M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.